Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Mobile reminder app to help people with chronic disease and memory loss stick to their meds

Official title: Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective - A Quasi Experimental Study

Run by Mansoura University · NCT07718334 · Data updated 2026-11-12

This study tests whether a smartphone reminder app can improve how well adults with chronic diseases and memory impairment take their prescribed medications.

More Chronic Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment193 (estimated)
SponsorMansoura University
Academic / other
Locations2 sites (Gamasa, Dakahlia Governorate and 1 other locations)
StatusRecruiting
StartedMay 10, 2026
Main results expectedSeptember 2026
Study endsSeptember 2026
Registry record updatedJuly 21, 2026
Trial IDNCT07718334 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults 18+ with a chronic disease and mild-to-moderate memory impairment who own a smartphone or have a caregiver to manage the app.

Probably not a fit

Patients with severe cognitive impairment or who cannot use or access a smartphone may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will use a quasi-experimental design to compare medication adherence before and after introducing a customized mobile reminder system for adults with chronic diseases and mild-to-moderate memory impairment. Participants will complete a baseline assessment, use the app to receive automated medication alerts for a set period, and then be reassessed to measure changes in adherence. The study aims to show how nursing leadership and mobile health tools can support patient independence and reduce complications from missed doses. Findings could inform care pathways that integrate digital reminders into routine management for cognitively affected patients.

Why it matters

Potential benefit: If successful, the app could help patients stay adherent to their medications, potentially improving health outcomes and reducing healthcare costs.

How similar studies have gone: Previous studies in similar populations suggest digital reminders can improve adherence, but results vary depending on technology design and support.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with one or more chronic diseases requiring regular long-term medication.
* Patients exhibiting mild-to-moderate memory impairment or cognitive decline as screened by the Mini-Mental State Examination (MMSE).
* Patients who personally own and are capable of operating a smartphone or have a primary caregiver willing to manage the mobile application.
* Patients aged 18 years and older.
* Patients who provide voluntary informed consent to participate in the study.

Exclusion Criteria:

* Patients with severe cognitive impairment or advanced dementia who cannot interact with mobile technology even with caregiver assistance.
* Patients with severe acute clinical complications or unstable psychiatric conditions.
* Patients participating in another concurrent clinical trial or study targeting medication adherence

Where it's running

  • Outpatient Clinics, Delta University for Science and Technology
    Gamasa, Dakahlia Governorate, Egypt
    Recruiting
  • Outpatient Clinics, Kafr El-Sheikh Hospital
    Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.